Wanbury’s subsidiary - Cantabria Pharma S.L., Spain, has filed petition for voluntary insolvency in the Commercial Courts of Madrid, Spain on November 04, 2013.
Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.